Take a deeper dive

Nuventra’s Webinar Library

Were you unable to attend our live webinars? Watch Nuventra’s past webinars and hear directly from some of our Senior Consultants who are experts on these Clinical Pharmacology topics.  Fill out the forms below for more details and to access our past webinars recordings.

Timing Considerations for Clinical Pharmacology Studies in Oncology Drug Development

Clinical pharmacology plans are not “one size fits all.” This is especially true for oncology, as the time from the first-in-human dose to approval is shorter for oncology relative to other indications and the medical need is substantial. Hear from Nuventra’s consultants, Gene Williams and Brian Furmanski as they present this webinar titled, “Timing Considerations for Clinical Pharmacology Studies in Oncology Drug Development.


The Path to IND – Roadblocks, Milestones, and Regulatory Strategy

The Investigational New Drug (IND) application is the primary pathway through which new drugs and biologics are approved to be tested in humans. But, what exactly is an IND and does your program really need one? What are the requirements for a successful IND and what paths can you take to get there? Hear From Todd Shearer, Ph.D. and Brian Furmanski, Ph.D., as they present this webinar titled, “The Path to IND – Roadblocks, Milestones, and Regulatory Strategy.


Addressing the Challenges of Drug Discovery and Delivery for Combination Peptide Therapeutics

There has been growing interest and activity in the use of peptide therapeutics to treat a variety of human diseases. This webinar will present approaches to discover, optimize, assess, and deliver combination peptide therapeutics for treatment of metabolic diseases. Hear from Nuventra’s Mark Bush PhD, and Intarcia Therapeutics’ Paul L. Feldman PhD, as they present this webinar titled, “Addressing the Challenges of Drug Discovery and Delivery for Combination Peptide Therapeutics.

Explore Our Blog

How to Successfully Prepare for Your Pediatric Study Plan

Although the implementation of laws surrounding the safety and efficacy of drugs and biologics started in the early 1900s, the…

Read More

What to Expect following Your Marketing Application Submission

Submitting a marketing application to the FDA is only the first in a cascade of events that lead to products…

Read More

Alzheimer’s Drug Development & Challenges to the Amyloid Hypothesis

In 2018, the FDA published a draft guidance on how to develop drugs to treat early Alzheimer’s Disease (AD). This…

Read More